TY - JOUR AU - Dr. Nami OP, PY - 2021/06/02 Y2 - 2024/03/28 TI - Healthcare Analytics JF - Drugs and Cell Therapies in Hematology JA - dcth VL - 9 IS - 2 SE - Articles DO - UR - http://www.dcth.org/index.php/journal/article/view/30 SP - 14 - 16 AB - <p><em>In healthcare analytics management, usage and storage, value estimates are nearly as impressive as the trends in underlying growth. For instance, it is projected that the health care sector in the US is likely to save $ 300 billion per year; upon adopting Healthcare analytics. In addition, effective leveraging of Healthcare analytics is associated with improved margin operations among retailers. Therefore, it is noteworthy that Healthcare analytics does not pose a level playing field. On one hand, large market opportunities exist regarding the performance of Healthcare analytics. On the other hand, some firms are inherently data-rich. Therefore, diversified operators gain access to massive amounts of information regarding sale points, providing unique insight pertaining to product preference, consumer behavior, trends in sales, and intelligence on the market. The implication is that Healthcare analytics enables the players in the market to outsmart their competition. Additionally, Healthcare analytics cannot be likened to a one-way street. Whereas its application may lead to greater satisfaction of product users through novel and lower prices, better quality, and on-time</em> delivery, the cost of gaining access to Healthcare analytics sets and maintaining them is relatively high.</p> ER -